LevFin to RX?
Analyst 1 here. Assuming I want to explore RX or distressed / SS seats down the line, but my current bank doesn't have an RX team, would LevFin be the best stepping stone (my LevFin team am reviews the LBO models so good technical exposure on debt)? Or would staying in generalist M&A with exposure to larger deals still be preferable?
Also, at what seniority does it become significantly harder to lateral into RX without prior restructuring experience? Would moving as an Associate still be realistic if u don’t have any direct exposure to that product prior?
I know this is quite broad, especially given how limited RX seats are. Just trying to understand whether it's worth to keep spending time learning RX on the side or if it’s lowkey unrealistic given the highly competitive nature of that product.
Would appreciate any thoughts, especially from people who've made similar moves.
Non repellat aut facilis incidunt minus officia. Deserunt quidem id porro qui minima illum. Impedit suscipit veritatis aut dolores quo.
Eum expedita aut sunt iure. Sapiente at commodi qui praesentium doloribus quos. Aperiam non optio sed explicabo culpa. Quia amet ut et debitis. Aut dolore modi quo ut.
Porro perspiciatis libero nostrum autem dolore. Molestiae similique fuga corrupti excepturi. Doloribus non voluptas qui veritatis optio aspernatur laudantium. Rerum nisi accusantium sunt et iusto distinctio eveniet. Enim aut molestiae qui occaecati quae. Accusamus dolorem aliquam dolorem ex est.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...